Suppression of tumor growth through disruption of hypoxia-inducible transcription

Nature Medicine

Volumn 6, Issue 12, 2000, Pages 1335-1340

  Kung, Andrew L ^a   Wang, Stream ^a   Klco, Jeffery M ^a   Kaelin, William G ^a   Livingston, David M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CLONING VECTOR; CONTROLLED STUDY; GENE DISRUPTION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; TRANSCRIPTION TERMINATION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; BINDING SITES; CELL HYPOXIA; CREB-BINDING PROTEIN; DNA-BINDING PROTEINS; E1A-ASSOCIATED P300 PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROTEIN BINDING; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0034529914     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/82146     Document Type: Article

References (45)

1. 2 homeostasis by hypoxia-inducible factor 1
2. 2 tension
3. HIF-1α protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by nypoxia depends on redox-induced changes
4. Activation of HIF depends primarily upon redox-sensitive stabilization of its α subunit
5. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
6. HIF-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
7. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
8. 2 tension
9. Dimerization, DNA binding, and transactivation properties of HIF-1
10. An essential role for p300/CBP in the cellular response to hypoxia
11. Regulation of transcription by hypoxia requires a multi-protein complex that includes HIF-1, an adjacent transcription factor, and p300/CREB binding protein
12. Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 co-activator by the HIF-1α
13. Redox-regulated recruitment of the transcriptional co-activators CRE8-binding protein and SRC-1 to HIF-1α
14. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
15. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity
16. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
17. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies
18. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
19. Overexpression of HIF-1α in common human cancers and their metastases
20. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
21. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
22. SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
23. An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer
24. Development of a hypoxia-responsive vector for tumor-specific gene therapy
25. Transactivation and inhibitory domains of HIF-1α. Modulation of transcriptional activity by oxygen tension
26. Identical short peptide sequences in unrelated proteins can have different conformations: A testing ground for theories of immune recognition
27. Role of CBP/P300 in nuclear receptor signalling
28. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein
29. The nuclear hormone receptor co-activator SRC-1 is a specific target of p300
30. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α
31. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
32. HIF-1α is required for solid tumor formation and embryonic vascularization
33. HIF-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
34. HIF-1α is a positive factor in solid tumor growth
35. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
36. Loss of PTEN facilitates HIF-1-mediated gene expression
37. Dimerization, DNA binding, and transactivation properties of HIF-1
38. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
39. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by C8P and p300
40. Pharmacological rescue of mutant p53 conformation and function
41. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
42. Tumor induction of VEGF promoter activity in stromal cells
43. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. Coli cytoplasm
44. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1